Influenza and pneumococcal vaccination: patient perceptions. Issue 894 (1st April 2000)

• Record Type: Journal Article
• Authors: Findlay, Paul F; Gibbons, Y M; Primrose, W R; Ellis, G; Downie, G
• Is Part Of: Postgraduate medical journal. Volume 76:Issue 894(2000)
• Page Start: 215
• Page End: 217
• Publication Date: 2000-04-01
• Subjects: influenza vaccine -- pneumococcal vaccine; Medicine -- Periodicals; 610
• DOI: 10.1136/pmj.76.894.215
• Languages: English
• ISSNs: 0032-5473

Abstract

Abstract : The efficacy of the influenza vaccine in reducing mortality and hospital admissions is established, particularly in the elderly. However, up to 50% of those at risk do not receive the vaccine. These patients are also at risk from pneumococcal infection and there is considerable overlap between the target group for each vaccine. This study sought to identify at risk individuals from consecutive admissions to an acute geriatric unit and to gain an insight into their perceptions with regard to vaccination. The awareness of each vaccine was recorded, together with the vaccination history. Seventy four per cent of the final cohort had heard of the influenza vaccine, while only 13% had heard of the pneumococcal vaccine. Fifty per cent perceived themselves to be at risk from influenza and its complications and 87% of the cohort believed it to be a serious infection. Influenza vaccine was judged to confer good protection by 72% of the sample and yet up to 50% believed that the vaccine can make the recipient ill. Influenza is perceived as a serious infection by patients and yet many do not believe themselves to be at particular risk. Although influenza vaccination is believed to confer protection, the decision whether, or not, to accept the vaccine is coloured by many factors, including popular myths and anecdotal information from friends and relatives. The uptake of influenza vaccine is suboptimal and the awareness of the pneumococcal vaccine certainly in the elderly is poor. The need for a comprehensive nationwide education campaign promoting both influenza and pneumococcal vaccine is highlighted.